AbbVieMEX:ABBV -0.19%72 Days Inventory is 108.09 as of Mar. 2026, which is 40% above its 10-year median of 77.46. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,712.75 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, AbbVie ranks better than 81.15% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). AbbVie's Average Total Inventories for the
three
months ended in Mar. 2026 was MXN90,097 Mil. AbbVie's Cost of Goods Sold for the
three
months ended in Mar. 2026 was MXN76,062 Mil.
Hence, AbbVie's Days Inventory for the
three
months ended in Mar. 2026 was 108.09.
The historical rank and industry rank for AbbVie's Days Inventory or its related term are showing as below:
MEX:ABBV'
s Days Inventory Range Over the Past 10 Years
Min: 60.76 Med: 77.46 Max: 98.98
Current: 96.79
During the past 13 years, AbbVie's highest Days Inventory was 98.98. The lowest was 60.76. And the median was 77.46.
MEX:ABBV's Days Inventory is ranked better than 81.15% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs MEX:ABBV: 96.79
AbbVie's Days Inventory
increased
from Mar. 2025 (100.19) to Mar. 2026 (108.09).
It might indicate that AbbVie's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
AbbVie's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AbbVie's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.33.
AbbVie (MEX:ABBV) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
AbbVie's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AbbVie's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
AbbVie Days Inventory Related Terms
AbbVie Days Inventory Historical Data
* Premium members only.
The historical data trend for AbbVie's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ABBV vs MRK, JNJ, AMGN: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, AbbVie's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's Days Inventory distribution charts can be found below:
* The bar in red indicates where AbbVie's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie (MEX:ABBV) has a Days Inventory of 108.09 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AbbVie and its competitors. This is 40% above median its historical median of 77.46. Over the past decade, AbbVie's Days Inventory has ranged from 60.76 to 98.98. According to the industry distribution chart, AbbVie ranks #173 out of 918 companies in the Drug Manufacturers industry, placing it in the top 18.8%.
Is AbbVie's Days Inventory too high?
AbbVie's current Days Inventory of 108.09 is 40% above median its 10-year median of 77.46. Over the past 10 years, this metric has ranged from a low of 60.76 to a high of 98.98. The Drug Manufacturers industry median Days Inventory is 164.43. AbbVie's value of 108.09 is 34.3% below this industry median. Based on the distribution chart, AbbVie ranks #173 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Days Inventory compare to MRK and JNJ?
According to the Drug Manufacturers industry distribution chart, AbbVie ranks #173 out of 918 companies for Days Inventory. This places AbbVie in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. AbbVie's value of 108.09 is 34.3% below this benchmark. Historically, AbbVie's own Days Inventory has ranged from 60.76 to 98.98 over the past decade. While the company's 10-year median is 77.46 vs. the industry median of 164.43, AbbVie has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AbbVie's current Days Inventory of 108.09 is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AbbVie and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AbbVie's current Days Inventory is 108.09, which is 40% above median its own 10-year median of 77.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,712.75, compared to a current price of MXN4,402.62 — trading 18.6% above its estimated fair value. The current Days Inventory is 108.09, which is 40% above median its 10-year median of 77.46 and 34.3% below the Drug Manufacturers industry median of 164.43. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current Days Inventory is 108.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AbbVie (MEX:ABBV) Overvalued in 2026?
Based on GuruFocus' analysis, AbbVie stock appears to be overvalued.
The current stock price of MXN4,402.62 is trading 18.6% above its estimated GF Value™ of MXN3,712.75.
GuruFocus considers AbbVie to be Modestly Overvalued.
Key valuation signals for MEX:ABBV:
Days Inventory: 108.09 (40% above median its 10-year median of 77.46)
GF Value™: MXN3,712.75 vs. price of MXN4,402.62 (18.6% above fair value)
Industry Position: 34.3% below the Drug Manufacturers median (#173 of 918)
No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score
Get the complete analysis for MEX:ABBV
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABBV has been successfully added to your 
